MPS DEMAND MORE NHS CONTROLS IN UK

6 December 1993

The UK House of Commons' public accounts committee has demanded that there should be stronger systems of management control and accountability in the National Health Service. These are needed, it says, to avoid any reccurance of the "grave shortcomings" uncovered in the West Midlands region, where at least L 10 million ($14.9 million) was wasted in the health authority's services organization management.

A report by the committee, quoted in the Financial Times, says that the essence of this mismanagement was that "the official, new to the NHS, was able to follow his own path, making a bonfire of the rules in the process, uncontrolled by either the regional health authority or regional senior management."

The committee adds that the NHS management executive should have been aware of problems in the West Midlands region much earlier. And, although the executive has taken action to tighten the procedures, the committee says that the present division of responsibility between the management executive and health authorities has "too much scope for negotiation and argument."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight